Direct access to content


Welcome to the Research Center for Respiratory Diseases INSERM UMR 1100


News



[JPG - 9 Ko]Guillon A, Brea D, Morello E, Tang A, Jouan Y, Ramphal R, Korkmaz B, Perez-Cruz M, Trottein F, O'Callaghan RJ, Gosset P, Si-Tahar M. Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense. Virulence. 2016 Oct 28:1-11. [Epub ahead of print] PubMed PMID: 27792459.
                                                   
            
[JPG - 7 Ko]
Discordance in cathepsin B and cystatin C expressions in bronchoalveolar fluids between murine bleomycin-induced fibrosis and human idiopathic fibrosis. Kasabova M, Villeret B, Gombault A, Lecaille F, Reinheckel T, Marchand-Adam S, Couillin I, Lalmanach G. Respir Res. 2016 Sep 22;17(1):118.                                                   
                                                                                                                                 
[JPG - 9 Ko]Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.

Bodier-Montagutelli E, Morello E, L'Hostis G, Guillon A, Dalloneau E, Respaud R, Pallaoro N, Blois H, Vecellio L, Gabard J, Heuzé-Vourc'h N. Expert Opin Drug Deliv. 2016 Nov 10:1-14. 













Research Center                         for Respiratory Diseases


Director : Mustapha SI TAHAR

3 INSERM teams

Contacts


  • Address
Research Center for Respiratory Diseases

Centre d'Etude des Pathologies Respiratoires (CEPR)
INSERM U1100
Faculté de Médecine, Université F. Rabelais
10, boulevard Tonnellé
37032 Tours cedex , France

  • Secretary
Aurélie HENRIQUES
Tél. : 33 (0)2.47.36.60.49
Fax : 
33 (0)2.47.36.60.46
 E-mail : secretariat.cepr@univ-tours.fr




Read the news of the university
Back to institution site